| Literature DB >> 36204095 |
Zhijia Zhou1, Jinghao Zhang1, Liping You1, Tao Wang1, Kaixia Wang1,2, Lingtai Wang1, Xiaoni Kong3, Yueqiu Gao1, Xuehua Sun1.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a global health problem, and its prevalence has been on the rise in recent years. Traditional Chinese Medicine (TCM) contains a wealth of therapeutic resources and has been in use for thousands of years regarding the prevention of liver disease and has been shown to be effective in the treatment of NAFLD in China. but the molecular mechanisms behind it have not been elucidated. In this article, we have updated and summarized the research and evidence concerning herbs and their active ingredients for the treatment in vivo and vitro models of NAFLD or NASH, by searching PubMed, Web of Science and SciFinder databases. In particular, we have found that most of the herbs and active ingredients reported so far have the effect of clearing heat and dispelling dampness, which is consistent with the concept of dampness-heat syndrome, in TCM theory. we have attempted to establish the TCM theory and modern pharmacological mechanisms links between herbs and monomers according to their TCM efficacy, experiment models, targets of modulation and amelioration of NAFLD pathology. Thus, we provide ideas and perspectives for further exploration of the pathogenesis of NAFLD and herbal therapy, helping to further the scientific connotation of TCM theories and promote the modernization of TCM.Entities:
Keywords: Dampness-heat syndrome; TCM; herbs; ingredients; non-alcoholic fatty liver disease (NAFLD)
Mesh:
Substances:
Year: 2022 PMID: 36204095 PMCID: PMC9530134 DOI: 10.3389/fendo.2022.1000727
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 6.055
Figure 1Current pathogenesis of NAFLD.
Figure 2The pathological factors of Gan-Pi and the corresponding classification of symptoms of ZHENGs in TCM theory. dampness-heat (shi-re in Chinese), phlegm (tan in Chinese), blood stasis (xue-yu in Chinese) and qi stagnation (qi-zhi in Chinese).
Figure 3Workflow of this review. Blue represents the causative factors of NAFLD, purple represents the method of classification of drugs and light yellow represents the different pathological mechanisms.
Main mechanisms of CHM treating Congestion of Dampness Turbidity of NAFLD and its complications by dispelling dampness (Qu Shi) and dissolving turbidity (Hua Zhuo).
| Active ingredients | Source (English name/pinyin) | Efficacy of TCM theory | Experimental model | Molecule Mechanisms | Pathological mechanism | Ref. |
|---|---|---|---|---|---|---|
| Alisol B 23-acetate | Alisma plantago-aquatica subsp. orientale (Sam.) Sam. [Alismataceae]/Ze-Xie | Diuresis and dampness infiltration | Hp3b,HepG2,Hela,Sk-br-3,Mda-MB-231,MCF-7,Pc3,C666-1 cell | Induces mobilization of internally stored calcium, leading to autophagy by activating the CAMKK-AMPK- pathway | 2,4 | ( |
| C57bl/6 mice MCD model | Activating farnesol X receptor | 1,3,5 | ( | |||
| Alisol A 24-acetate | Apoe−/− mice model | Alisol A24-acetate improved liver lipid deposition through ABCA1/ABCG1 pathway. | 2 | ( | ||
| T3-l1 mouse fibroblast cell model | Activation of PKA-mediated hormone-sensitive lipase phosphorylation and ERK-mediated down-regulation of perilipin A | 2 | ( | |||
| ICR mice lipid emulsion-induced model | Binding to 3-hydroxy-3-methylglutary-coenzyme A (HMG-CoA) reductase, | 2 | ( | |||
| Alismatis rhizoma triterpenes | C57bl/6j mice HFD model";"C2C12 cells model | Promoting IR by elevated GLUT4 expression | 6,9 | ( | ||
| Methanol extract of the tuber of Alisma plantago-aquatica subsp. orientale (Sam.) Sam. [Alismataceae] | Tunicamycin-induced and HFD induced C57bl/6 mice model";"tunicamycin-treated and pa-treated HepG2 cell | Inhibition of expression of the hepatic lipogenic genes and VLDLR, and enhancement of Apoe secretion to improve ER stress | 1 | ( | ||
| Alisma plantago-aquatica subsp. orientale (Sam.) Sam. [Alismataceae]extract | Sprague dawley (SD) rats HFD model | Altering intestinal microecology and regulating genes related to cholesterol metabolism | 2,8 | ( | ||
| Nuciferine | Nelumbo nucifera Gaertn. [Nelumbonaceae]/He-Ye | Oleic acid (OA)-induced HepG2 cells | Regulate Per-Arnt-Sim kinase expression | 1,2,3 | ( | |
| golden Syrian hamsters fed HFD model | Regulate FFA infiltration, inflammation and oxidative stress | 1,2,3 | ( | |||
| SD rats fed HFD model | Improve glycerophospholipid, linoleic acid, alpha-linolenic acid, arginine, and proline metabolism pathways | 2 | ( | |||
| Diosgenin | Trigonella foenum-graecum L. [Fabaceae]/Hu-Lu-Ba | L02 cells incubated with palmitic acid | By activating AMPK/ACC/CPT-1A and inhibiting SREBP-1c/FAS signaling pathway | 2,3 | ( | |
| Resveratrol | Reynoutria japonica Houtt. [Polygonaceae]/Hu-Zhang | HepG2 cells. Incubated with oleic acid and palmitic acid | Limit the intake and synthesis of lipids and reduce oxidative stress. | 1,2 | ( | |
| HFD fed C57/bl6 mice model";"HepG2 cells treated with d-glucose model | Reduce the methylation level of Nrf2 promoter | 2,6 | ( | |||
| HFD fed SD rats model | Improve liver and glucose and lipid metabolism disorders, improve behavioral and cognitive impairment | 2 | ( | |||
| PA-induced HepG2 cell | Improve lipid metabolism and redox homeostasis and oxidative stress by activating the PKA/AMPK/PPARα signaling pathway | 1,2 | ( | |||
| 129/svj mice induced by HFD diet model";"HepG2 cells treated with PA | Stimulate fatty acid β-oxidation by inducing autophagy through the camp-Pka-Ampk-Sirt1 signaling pathway | 4 | ( | |||
| HepG2 cells induced by high glucose | Limit lipogenesis and enhance mitochondrial activity | 2 | ( | |||
| SD rats fed HFD model | Induce gut barrier impairment by inhibiting colonic CB1, and abrogates the aggravated intestinal inflammation | 8 | ( | |||
| C57bl/6 j mice fed HFD model | Improve the intestinal microenvironment, including gut barrier function and gut microbiota composition. | 8 | ( | |||
| C57bl/6j mice fed HFD model | Improve insulin sensitivity and lipid metabolism by increasing the abundance of intestinal specific bacteria | 2,8 | ( | |||
| Wistar rats fed HFD model | Improve inflammatory oxidative stress | 1,3 | ( | |||
| C57bl/6 mice were treated with MCD model aml12 cells were treated with MCD model | Attenuate hepatic steatosis and inflammation in MCD-induced NASH by regulating autophagy | 1,3 | ( | |||
| Wistar rats fed HFD model | Down-regulate GPAT-1 and Dgat2 expression and inhibit PKC membranous translocation | 9 | ( | |||
| Wistar rats fed HFD model | Improve liver function by up regulating the expression of SIRT1, LXR and FXR | 6 | ( | |||
| Ulk1+/- mice fed with HFD model | Regulation of autophagy and NF- kappa B activity | 3, 4 | ( | |||
| Pterostilbene | Wistar rats induced by high-fat high-fructose | Higher antioxidant and anti-inflammatory activities | 1,3 | ( | ||
| Resveratrol-curcumin hybrid, a19 | C57bl/6 mice fed with HFD model";" mouse primary peritoneal macrophage and HepG2 cell treated with PA | Down-regulated the inflammatory response";"reduce PA-induced ERK phosphorylation | 3 | ( | ||
| Pocu1b | SD rats fed HFD model | Inhibitions of pancreatic lipase, cAMP-dependent PDE activity, AMPK activation, and SOCS-3 suppression | 2,3,9 | ( | ||
| Polydatin | SD rats fed HFD model | Inhibiting the expression of TNF-α and srebp-1c | 2,3 | ( | ||
| SD rats fed HFD model | Improved insulin receptor substrate 2 expression levels and AKT phosphorylation | 9 | ( | |||
| C57bl/ksj-db-/db (db/db) Mice fed HFD model | Up regulating the transcription factor TFEB and subsequently restoring the lysosomal clearance of autophagosomes. | 4 | ( | |||
| The ethanolic extract of adlay seeds | Coix lacryma-jobi L. [Poaceae]/Yi-Yi-Ren | C57bl/6j mice fed HFD model | Inhibition of lipogenesis and induction of fatty acid β oxidation in liver | 2 | ( | |
| Coix lacryma-jboi seed oil | Wistar rats fed HFD model | Inhibiting the p-AMPK/SEPP1/APOER2 pathway | 2 | ( | ||
| – | Chaenomeles lagenaria (Loisel.) Koidz. [Rosaceae]/Mu-Gua | Wind-cold-damp Expelling | Sprague-dawley rats fed HFD model | Reduce the accumulation of lipids in the liver, inhibit the lipogenic pathway, improve the balance of antioxidation and reduce inflammation | 2,3 | ( |
| Pinolenic acid | Pinus tabuliformis Carrière [Pinaceae]/Song-Zi-Ren | Oleic acid (OA)-induced L02 cells and HepG2 cell model | Improving lipogenesis and oxidative stress by regulating AMPK/SIRT1 signaling pathway | 2,3 | ( |
The current pathological mechanism of NAFLD:1.oxidative stress (OS) or ER stress, 2.abnormal lipid metabolism, 3. inflammation, 4.cell regeneration, 5.fibrosis, 6.genetic predisposition, 7.innate immune disorder, 8.intestinal flora imbalance 9. insulin resistance.
Chinese patent medicine treating NAFLD target to DHS.
| Compounds | Prescriptions | Register ID | Status |
|---|---|---|---|
| Da Huang Li Dan Pills | Rheum palmatum L. [Polygonaceae]/(Da-Huang),Gymnadenia orchidis Lindl./(Shou-Zhang-Shen),Phyllanthus emblica L. [Phyllanthaceae]/(Yu-Gan-Zi) | – | approved |
| Huazhi Rougan Granule | Artemisia capillaris Thunb. [Asteraceae]/(Yin-Chen)Senna tora (L.) Roxb. [Fabaceae]/(Jue-Ming-Zi)Rheum palmatum L. [Polygonaceae]/(Da-Huang)Alisma plantago-aquatica L. [Alismataceae]/(Ze-Xie)Polyporus umbellatus/(Zhu-Ling)Crataegus pinnatifida var. pinnatifida [Rosaceae]/(Shan-Zha)Atractylodes lancea (Thunb.) DC. [Asteraceae]/(Cang-Zhu)Atractylodes macrocephala Koidz. [Asteraceae]/(Bai-Zhu)Citrus × aurantium L. [Rutaceae]/(Chen-Pi)Trichosanthes kirilowii Maxim. [Cucurbitaceae]/(Gua-Lou)Ligustrum lucidum W.T.Aiton [Oleaceae]/Nv-Zhen-Zi)Eclipta prostrata (L.) L. [Asteraceae]/(Mo-Han-Lian)Lycium barbarum L. [Solanaceae]/(Gou-Qi-Zi)Cirsium arvense (L.) Scop. [Asteraceae]/(Xiao-Ji)Bupleurum falcatum L. [Apiaceae]/(Chai-Hu)Glycyrrhiza glabra L. [Fabaceae]/(Gan-Cao) | – | approved |
| Dang Fei Li Gan Capulse | Silybum marianum (L.) Gaertn. [Asteraceae]/(Shui-Fei-Ji), Swertia pseudochinensis H.Hara [Gentianaceae]/(Dang-Yao) | – | approved |
| Shu gan zhi Tables | Bupleurum falcatum L. [Apiaceae]/(Chai-Hu)Citrus × aurantium L. [Rutaceae]/(Zhi-Qiao)Curcuma aromatica Salisb. [Zingiberaceae]/(E-Zhu)Seaweed/(Hai-Zao)Atractylodes lancea (Thunb.) DC. [Asteraceae]/(Cang-Zhu)Tuckahoe/(Fu-Ling)Atractylodes macrocephala Koidz. [Asteraceae]/(Bai-Zhu)Carthamus tinctorius L. [Asteraceae]/(Hong-Hua)Panax notoginseng (Burkill) F.H.Chen [Araliaceae]/(San-Qi)Crataegus pinnatifida var. pinnatifida [Rosaceae]/(Shan-Zha)Astragalus mongholicus Bunge [Fabaceae]/(Huang-Qi)Sargentodoxa cuneata (Oliv.) Rehder & E.H.Wilson [Lardizabalaceae]/(Da-Xue-Teng) | CTR20180031 | IIa |
| Dan Shao Gan Kang Granules | Bupleurum falcatum L. [Apiaceae]/(Chai-Hu)Astragalus mongholicus Bunge [Fabaceae]/(Huang-Qi)Angelica sinensis (Oliv.) Diels [Apiaceae]/(Dang-Gui)Paeonia lactiflora Pall. [Paeoniaceae]/(Bai-Shao)Salvia miltiorrhiza Bunge [Lamiaceae]/(Dan-Shen)Schisandra chinensis (Turcz.) Baill. [Schisandraceae]/(Wu-Wei-Zi) | CTR20140038 | IIb |
Figure 4The regulatory effects on pathways induced by a group of ingredients from dispelling dampness (Qu Shi) and dissolving turbidity (Hua Zhuo) herbs.
Figure 6The relationship between (A) anti-dampness herbs and their active components, (B) clearing-heat herbs and their active components and the current pathological factors of NAFLD. The inner part is the pathological mechanism of NAFLD, the middle represents the corresponding herbs, and the outside is their active components. The colors represent the different molecular mechanisms of pathology and the size represents the proportion of the current study. The names of the individual herbs are given in Chinese and the corresponding English names are detailed in , .
Main mechanisms of CHM treating NAFLD and its complications by Heat-Clearing (Qing Re).
| Active ingredients | Source (latin or English name/pinyin) | Efficacy of TCM theory | Experimental model | Molecule Mechanisms | Pathological mechanism | Ref. |
|---|---|---|---|---|---|---|
| 14-Deoxy-11, 12-Didehydroandrographolide | Andrographis paniculata (Burm.f.) Nees [Acanthaceae]/Chuan-Xin-Lian | Clearing heat and detoxification | C57BL/6J mice fedHFHC model | Reduce cholesterol accumulation, antioxidant and anti-inflammatory activities | 1,2 | ( |
| Isandrographolide | Wistar rats fed HFD model | Improve efficacy on hyperlipidemia and fat accumulation in the liver | 2 | ( | ||
| Ursodeoxycholic acid | Bear bile/Xiong-Dan | SD rats fed HFD model | Inhibition of apoptosis and promotion of autophagy by activating AMPK pathway | 4 | ( | |
| L02 cell stimulated with OA model | Regulate the AKT/mTOR/SREBP-1 signaling pathway | 1,2 | ( | |||
| Genipin | Gardenia jasminoides J.Ellis [Rubiaceae]/Zhi-Zi | Aging SD rats model";"palmitate-treated L02 cell model | Inhibiting hepatic oxidative stress and mitochondrial dysfunction | 1 | ( | |
| C57BL/6J mice fed HFD model | Reverses HFD-induced liver damage and inhibits UCP2-mediated pyroptosis | 4 | ( | |||
| Geniposide | Tyloxapol- induced C57BL/6J mice model";"HepG2 cell induced by OA or PA model | Enhancing the ability of antioxidative stress and inflammation by up-regulating the protein expression of Nrf2/HO-1 and AMPK signaling pathways | 1,3 | ( | ||
| Free Fatty Acid-Treated HepG2 Cell model";" | Suppressed the intra- cellular lipid accumulation by increasing the expression of PPARα | 2 | ( | |||
| C57BL/6 mice fed HFD model | Down-regulate RHOA/ROCK signal and improve intestinal Barrier | 8 | ( | |||
| Wistar Rats fed HFD model | Improve fatty acid metabolism by regulating the AMPK–Malonyl-CoA-FFA axis. | 2 | ( | |||
| GJ extract | LPS induced BV-2 cells model";"LPS induced AD rats model | Improve inflammation by suppression of JNK2/1 signaling pathways | 2,3 | ( | ||
| SD rats fed HFD model | Reduction of TNF-α and IL6 in adipose tissue | 3 | ( | |||
| Cassia semen ethanol extract | Senna tora (L.) Roxb. [Fabaceae]/Jue-Ming-Zi | Wistar rats fed HFD model | The antioxidant effect through increased the levels of TNF-α, IL-6, IL-8 and MDA | 1 | ( | |
| Baicalin | Scutellaria baicalensis Georgi [Lamiaceae]/Huang-Qin | Heat-clearing and Fire-draining | KK-A mice and C57BL/6J mice OA-induced model";"Sodium oleate-induced cell model | Prevent lipotoxicity through the AMPK-mediated SREBP signaling pathway. | 2,3 | ( |
| HepG2 cells treated FFA model | Reduce proptosis of hepatocyte by blocking NLRP3–GSDMD signaling | 4 | ( | |||
| Baicalein | Oleic acid-induced HepG2 cells";" HFD-induced mice model | Activating AMPK and suppressing SREBP1 cleavage | 1,2 | ( | ||
| MCD diet-induced mice C57BL/6J model | Attenuate lipid metabolism, inflammation and fibrosis in mice by suppressing key regulators such as SREBP-1c, FASN, PPARα ";"TNF-α, IL-1β ";"α-SMA and TGF-β1 and Col1A1 | 2,3,5 | ( | |||
| Oxymatrine | Sophora flavescens Aiton [Fabaceae]/Ku-Shen | High-fructose diet-induced Wistar rats’ model | Increase the mRNA and protein levels of PPA Rα 、CPT1and MTTP to decrease lipid accumulation in the liver | 2 | ( | |
| Matrine | C57BL/6J mice fed MCD model | Enhancing HSP72 and downregulating MTOR to improve inflammation and fibrosis | 3,5 | ( | ||
| C57BL/6J mice fed HFD model | Regulation of SERCA pathway reduces ER stress and mitochondrial dysfunction | 1 | ( | |||
| Water Extract of Artemisia annua L. | Artemisia annua L. [Asteraceae]/Qing-Hao | Clearing deficiency heat | HepG2 cell treated with oleic acid or tert-butylhydroperoxide model; C57BL/6J mice fed HFD model | ImproveLipid Accumulation and Oxidative Stress | 1,2 | ( |
| Rhein | Rheum palmatum L. [Polygonaceae]/Da-Huang | Purging fire and detoxification | C57BL/6J mice fed HFD model; LXR-/-Mice model; Hepa1–6 cell lines and Splenic mononuclear cell | Down-regulate lipogenesis through LXR-mediated SREBP-1c and shift the imbalanced Th1/Th2 response in the liver by modulation of cytokine signaling | 2,7 | ( |
| 3T3-L1 adipocytes and HepG2 cells ";"C57BL/6J mice fed HFD model";"db/db Mice";"LXRα/β knockout (LXR–/–)mice | Activate the UCP1 gene by antagonizing the repressive effect of LXR on UCP1 expression to Improve lipid metabolism | 2,6 | ( | |||
| Rhein lysinate | C57BL/J mice and KK/hlj mice fed HFD model | Decrease the expression of TNF-α, IL-6, NF-κB, SREBP-1c and Fas in liver | 2,3 | ( | ||
| Emodin | Zebrafish fed Egg yolk powder model | Reduce hepatic lipogenesis by Regulation of AMPK Signaling Pathway | 2 | ( | ||
| HepG2 cell treated with FAA";"SD rats fed HFD model | Alleviate hepatic lipid accumulation by inhibiting SREBP1 activity | 2 | ( | |||
| SD rats fed liquid fructose model | Improve the lipid accumulation through the ERS–SREBP 1c pathway | 1,2 | ( | |||
| – | SD rats fed HFD model | Attenuate excess fat accumulation by promoting the activity of AMPK and decreasing the gene expression of the biosynthesis of fatty acids and TG. | 2 | ( | ||
| – | Aloe vera (L.) Burm.f. [Asphodelaceae]/Lu-Hui | SD rats fed HFHFD model | Reduce oxidative stress, liver inflammation | 2,3 | ( | |
| Aloin | Nrf2 KO (Nrf2−/−) C57BL/6J mice model fed CDAAH diet model | Enhance antioxidant, anti-inflammatory and anti-apoptotic activity by activating Nrf2/HO-1 signaling | 2,3,4 | ( |
sThe current pathological mechanism of NAFLD:1.oxidative stress (OS) or ER stress, 2. abnormal lipid metabolism, 3. inflammation, 4.cell regeneration, 5.fibrosis, 6.genetic predisposition, 7.innate immune disorder, 8.intestinal flora imbalance 9. insulin resistance.
CDAAH diet: choline-deficient, L-amino acid- defined, high-fat (CDAAH) diet; HFHFD:high-fat high-fructose diet
Figure 5The regulatory effects on pathways induced by a group of ingredients from Heat-Clearing (Qing Re) herbs.